Behind the science
Why young people are at risk of meningitis and what needs to change to reduce it
It’s a time of life when many may feel invincible, but adolescents are at risk of invasive meningococcal disease (IMD), a bacterial infection that can be life-threatening. Better disease awareness and knowledge about preventative options could help protect young people from the potentially devastating consequences.
Our purpose
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.